Skip to main content
placeholder image

1390P Efficacy of anamorelin in advanced non-small cell lung cancer (NSCLC) patients with anorexia/cachexia and modified Glasgow Prognostic Score (mGPS) of 2: Pooled analysis of two phase 3 trials

Journal Article


Abstract


Publication Date


  • 2017

Citation


  • Kaasa, S., Laird, B., Fallon, M., McMillan, D., Skipworth, R., Currow, D., & Giorgino, R. (2017). 1390P Efficacy of anamorelin in advanced non-small cell lung cancer (NSCLC) patients with anorexia/cachexia and modified Glasgow Prognostic Score (mGPS) of 2: Pooled analysis of two phase 3 trials. Annals of Oncology, 28, v498. doi:10.1093/annonc/mdx382.005

Web Of Science Accession Number


Start Page


  • v498

Volume


  • 28

Issue


Place Of Publication


Abstract


Publication Date


  • 2017

Citation


  • Kaasa, S., Laird, B., Fallon, M., McMillan, D., Skipworth, R., Currow, D., & Giorgino, R. (2017). 1390P Efficacy of anamorelin in advanced non-small cell lung cancer (NSCLC) patients with anorexia/cachexia and modified Glasgow Prognostic Score (mGPS) of 2: Pooled analysis of two phase 3 trials. Annals of Oncology, 28, v498. doi:10.1093/annonc/mdx382.005

Web Of Science Accession Number


Start Page


  • v498

Volume


  • 28

Issue


Place Of Publication